AbbVie (ABBV) revenue was $61.2B in FY2025 (+9% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$61.2B
+9%
2024
$56.3B
+4%
2023
$54.3B
-6%
2022
$58.1B
+3%
2021
$56.2B
+23%
2020
$45.8B
+38%
2019
$33.3B
+2%
2018
$32.8B
+16%
2017
$28.2B
+10%
2016
$25.6B
+12%
2015
$22.9B
+15%
2014
$20.0B
+6%
2013
$18.8B
+2%
2012
$18.4B
+5%
2011
$17.4B
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$17.0B
Q1 2026
$15.0B
Q4 2025
$16.6B
Q3 2025
$15.8B
Q2 2025
$15.4B
Q1 2025
$13.3B
Q4 2024
$15.1B
Q3 2024
$14.5B
Q2 2024
$14.5B
Q1 2024
$12.3B
Q4 2023
$14.3B
Q3 2023
$13.9B
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.